Research Article
Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind, Placebo-Controlled Clinical Study
Table 3
The change of liver enzymes and inflammatory parameters at baseline and after eight weeks of UDCA or placebo treatment.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are expressed as median (IQR). , and : Mann–Whitney test compared with UDCA group. †: Wilcoxon’s signed rank test compared 8 weeks and baseline in the UDCA group. F0: beginning of study; F1: end of study; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transferase; CRP: C reactive protein; IL-6: interleukin-6. |